• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long non-coding RNA ELDR enhances oral cancer growth by promoting ILF3-cyclin E1 signaling.长非编码 RNA ELDR 通过促进 ILF3-cyclin E1 信号促进口腔癌生长。
EMBO Rep. 2020 Dec 3;21(12):e51042. doi: 10.15252/embr.202051042. Epub 2020 Oct 12.
2
Long noncoding RNA ELDR promotes cell cycle progression in normal oral keratinocytes through induction of a CTCF-FOXM1-AURKA signaling axis.长非编码 RNA ELDR 通过诱导 CTCF-FOXM1-AURKA 信号轴促进正常口腔角质细胞的细胞周期进程。
J Biol Chem. 2022 May;298(5):101895. doi: 10.1016/j.jbc.2022.101895. Epub 2022 Apr 1.
3
Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.长链非编码 RNA CCAT1 通过 miR-181a 介导的 Wnt/β-catenin 信号通路促进口腔鳞状细胞癌的进展,是其预后的生物标志物。
Cell Cycle. 2019 Nov;18(21):2902-2913. doi: 10.1080/15384101.2019.1662257. Epub 2019 Sep 4.
4
Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.长链非编码 RNA SLC16A1-AS1:在口腔鳞状细胞癌中的多种肿瘤发生特征及其对细胞周期的调控作用。
Cell Cycle. 2020 Jul;19(13):1641-1653. doi: 10.1080/15384101.2020.1762048. Epub 2020 May 25.
5
LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.长链非编码RNA,TUG1可能通过与Wnt/β-连环蛋白信号通路相互作用来调节口腔鳞状细胞癌的进展。
Gene. 2017 Apr 15;608:49-57. doi: 10.1016/j.gene.2017.01.024. Epub 2017 Jan 22.
6
Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.长链非编码 RNA 在肝癌中高表达可促进口腔鳞状细胞癌中的上皮-间充质转化过程。
J Cell Mol Med. 2019 Apr;23(4):2645-2655. doi: 10.1111/jcmm.14160. Epub 2019 Jan 24.
7
Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.长链非编码 RNA OIP5-AS1 通过调控 miR-338-3p/NRP1 轴促进口腔鳞状细胞癌的进展。
Biomed Pharmacother. 2019 Oct;118:109259. doi: 10.1016/j.biopha.2019.109259. Epub 2019 Jul 29.
8
An Axis between the Long Non-Coding RNA and NQOs Enhances Metastatic Ability in Oral Squamous Cell Carcinoma.长链非编码 RNA 和 NQO 之间的轴增强口腔鳞状细胞癌的转移能力。
Int J Mol Sci. 2022 Sep 14;23(18):10704. doi: 10.3390/ijms231810704.
9
Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.长链非编码RNA HCG11的下调通过吸附miR-455-5p促进口腔鳞状细胞癌的细胞增殖。
J Gene Med. 2021 Mar;23(3):e3293. doi: 10.1002/jgm.3293. Epub 2021 Jan 27.
10
Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.长链非编码RNA MALAT1通过诱导口腔鳞状细胞癌的上皮-间质转化促进肿瘤生长和转移。
Sci Rep. 2015 Nov 2;5:15972. doi: 10.1038/srep15972.

引用本文的文献

1
PINX1 inhibits proliferation and cisplatin resistance in nasopharyngeal carcinoma by promoting ILF3 ubiquitination.PINX1通过促进ILF3泛素化抑制鼻咽癌的增殖和顺铂耐药性。
Am J Cancer Res. 2025 Jun 15;15(6):2518-2534. doi: 10.62347/WFER2605. eCollection 2025.
2
LncRNA HOXB-AS4 Promotes Tumor Malignant Phenotype in Head and Neck Squamous Cell Carcinoma and Serves as a Prognosis Marker.长链非编码RNA HOXB-AS4促进头颈部鳞状细胞癌的肿瘤恶性表型并作为预后标志物。
J Cancer. 2025 Jul 1;16(9):2997-3014. doi: 10.7150/jca.111037. eCollection 2025.
3
Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of ILF3.靶向MYOF通过破坏OTUB1介导的ILF3去泛素化来抑制ILF3-LCN2信号传导,从而抑制胰腺导管腺癌的进展。
Redox Biol. 2025 Jul;84:103665. doi: 10.1016/j.redox.2025.103665. Epub 2025 May 11.
4
Disrupting lipid homeostasis with CAV2 in OSCC triggers apoptosis, lipolysis, and mitochondrial dysfunction by transcriptional repression of PPARγ.在口腔鳞状细胞癌中,通过CAV2破坏脂质稳态会通过PPARγ的转录抑制触发细胞凋亡、脂解作用和线粒体功能障碍。
Cell Biosci. 2025 May 14;15(1):59. doi: 10.1186/s13578-025-01399-6.
5
Long non-coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application.长链非编码RNA作为头颈部鳞状细胞癌的治疗靶点及临床应用
FEBS Open Bio. 2025 Apr 15. doi: 10.1002/2211-5463.70042.
6
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer.基于ceRNA网络的三阴性乳腺癌预后模型的开发。
PeerJ. 2025 Feb 27;13:e19063. doi: 10.7717/peerj.19063. eCollection 2025.
7
Rho GTPase activating protein 11A promotes tongue squamous cell carcinoma proliferation and is a transcriptional target of forkhead box M1.Rho GTP酶激活蛋白11A促进舌鳞状细胞癌增殖,并且是叉头框M1的转录靶点。
J Dent Sci. 2024 Oct;19(4):2268-2277. doi: 10.1016/j.jds.2024.02.015. Epub 2024 Feb 29.
8
Novel insights on oral squamous cell carcinoma management using long non-coding RNAs.利用长非编码 RNA 对口腔鳞状细胞癌管理的新见解。
Oncol Res. 2024 Sep 18;32(10):1589-1612. doi: 10.32604/or.2024.052120. eCollection 2024.
9
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.口腔癌中的非编码RNA:新兴作用与临床应用
Cancers (Basel). 2023 Jul 25;15(15):3752. doi: 10.3390/cancers15153752.
10
Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.基于失巢凋亡相关长非编码 RNA 预测透明细胞肾细胞癌的预后、免疫治疗及区分冷肿瘤和热肿瘤。
Front Immunol. 2023 Jun 9;14:1145450. doi: 10.3389/fimmu.2023.1145450. eCollection 2023.

本文引用的文献

1
Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.苦瓜提取物抑制口腔癌细胞的关键代谢途径:糖酵解和脂肪生成。
Cell Commun Signal. 2019 Oct 21;17(1):131. doi: 10.1186/s12964-019-0447-y.
2
Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis.与口腔黏膜下纤维化恶性进展相关的长链非编码RNA表达谱
J Oncol. 2019 Jul 29;2019:6835176. doi: 10.1155/2019/6835176. eCollection 2019.
3
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression.抑制细胞周期蛋白 E1 通过抑制 MCL-1 使肝癌细胞对regorafenib 敏感。
Cell Commun Signal. 2019 Jul 26;17(1):85. doi: 10.1186/s12964-019-0398-3.
4
Clinical update on head and neck cancer: molecular biology and ongoing challenges.头颈部癌症的临床新进展:分子生物学和当前面临的挑战。
Cell Death Dis. 2019 Jul 15;10(8):540. doi: 10.1038/s41419-019-1769-9.
5
Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications.口腔鳞状细胞癌中的长非编码 RNA:生物学功能、机制及临床意义。
Mol Cancer. 2019 May 27;18(1):102. doi: 10.1186/s12943-019-1021-3.
6
ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker.ILF3 促进胃癌增殖,可作为预后标志物。
Mol Med Rep. 2019 Jul;20(1):125-134. doi: 10.3892/mmr.2019.10229. Epub 2019 May 9.
7
Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB.口腔肿瘤细胞赖氨酰氧化酶样2在癌症发展中的机制:与血小板衍生生长因子AB的协同作用
Oncogenesis. 2019 May 13;8(5):34. doi: 10.1038/s41389-019-0144-0.
8
Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways.敲低头颈部癌细胞中的 PCAT-1 通过调控 c-Myc-AKT1-p38 MAPK 信号通路抑制肿瘤生长并诱导细胞凋亡。
BMC Cancer. 2019 Apr 15;19(1):354. doi: 10.1186/s12885-019-5562-z.
9
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.致癌剪接因子 SRSF3 通过调节 ILF3 的可变剪接促进癌细胞增殖和转化。
RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
10
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer.细胞周期蛋白E1和Rb调节是激素受体阳性乳腺癌对哌柏西利产生耐药时的常见事件。
NPJ Breast Cancer. 2018 Nov 28;4:38. doi: 10.1038/s41523-018-0092-4. eCollection 2018.

长非编码 RNA ELDR 通过促进 ILF3-cyclin E1 信号促进口腔癌生长。

Long non-coding RNA ELDR enhances oral cancer growth by promoting ILF3-cyclin E1 signaling.

机构信息

Department of Pathology, Saint Louis University, Saint Louis, MO, USA.

Department of Biology, Saint Louis University, Saint Louis, MO, USA.

出版信息

EMBO Rep. 2020 Dec 3;21(12):e51042. doi: 10.15252/embr.202051042. Epub 2020 Oct 12.

DOI:10.15252/embr.202051042
PMID:33043604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7726807/
Abstract

Oral squamous cell carcinoma (OSCC) is the sixth most common cancer with a 5-year overall survival rate of 50%. Thus, there is a critical need to understand the disease process, and to identify improved therapeutic strategies. Previously, we found the long non-coding RNA (lncRNA) EGFR long non-coding downstream RNA (ELDR) induced in a mouse tongue cancer model; however, its functional role in human oral cancer remained unknown. Here, we show that ELDR is highly expressed in OSCC patient samples and in cell lines. Overexpression of ELDR in normal non-tumorigenic oral keratinocytes induces cell proliferation, colony formation, and PCNA expression. We also show that ELDR depletion reduces OSCC cell proliferation and PCNA expression. Proteomics data identifies the RNA binding protein ILF3 as an interacting partner of ELDR. We further show that the ELDR-ILF3 axis regulates Cyclin E1 expression and phosphorylation of the retinoblastoma (RB) protein. Intratumoral injection of ELDR-specific siRNA reduces OSCC and PDX tumor growth in mice. These findings provide molecular insight into the role of ELDR in oral cancer and demonstrate that targeting ELDR has promising therapeutic potential.

摘要

口腔鳞状细胞癌(OSCC)是第六种最常见的癌症,其 5 年总生存率为 50%。因此,迫切需要了解疾病的发生过程,并确定改善治疗策略。以前,我们在一个舌癌小鼠模型中发现长非编码 RNA(lncRNA)表皮生长因子受体长非编码下游 RNA(ELDR)诱导表达;然而,其在人口腔癌中的功能作用仍不清楚。在这里,我们表明 ELDR 在 OSCC 患者样本和细胞系中高度表达。ELDR 在正常非肿瘤性口腔角质形成细胞中的过表达诱导细胞增殖、集落形成和 PCNA 表达。我们还表明,ELDR 的缺失减少了 OSCC 细胞的增殖和 PCNA 的表达。蛋白质组学数据鉴定出 RNA 结合蛋白 ILF3 是 ELDR 的相互作用伙伴。我们进一步表明,ELDR-ILF3 轴调节细胞周期蛋白 E1 的表达和视网膜母细胞瘤(RB)蛋白的磷酸化。ELDR 特异性 siRNA 的肿瘤内注射减少了小鼠中的 OSCC 和 PDX 肿瘤生长。这些发现为 ELDR 在口腔癌中的作用提供了分子见解,并表明靶向 ELDR 具有有前途的治疗潜力。